ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 15 | Q4 15 | Q1 16 | Q3 16 | Q4 16 | Q1 17 | Q3 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -38.8% | +20.3% | -32.9% | -2.5% | +129.1% | +19.0% | +200.0% | +26.7% | +54.7% | -8.8% | +2.2% | +2.9% | -14.2% | +33.1% | -11.2% | +2.1% | +1.4% | +123.6% | -15.7% | -27.6% | -2.0% | -34.8% | +46.5% | -5.8% | +4.5% | -0.5% | +1.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.9% | -1.3% | -51.8% | -28.0% | -39.3% | -6.1% | +3,543.7% | +3.4% | +30.5% | +20.6% | -7.8% | +21.9% | -7.3% | -16.5% | -19.9% | -22.4% | -8.4% | -18.3% | +54.3% | +40.0% | -8.7% | +51.9% | -0.2% | -3.1% | -36.2% | -32.4% | +5.8% | -33.0% | -46.5% | -59.2% | +76.1% | +84.7% | +71.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -3.9% | +212.3% | -24.6% | |
| – | -16.5% | -7.9% | -15.8% | -34.1% | -32.6% | +57.5% | +1,135.6% | +111.4% | -17.5% | +24.2% | -15.6% | +19.8% | -10.8% | -10.2% | -14.9% | -23.1% | -17.1% | -8.4% | +46.7% | +54.0% | -21.7% | +14.7% | -5.9% | -5.5% | -31.6% | -15.9% | -9.5% | -25.3% | -12.8% | -64.6% | +29.5% | +139.9% | +17.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +2,757.0% | +287.5% | -79.4% | – | – | – | – | – | -2.7% | -1.7% | -8.8% | -15.8% | -5.8% | -2.4% | -18.5% | +22.7% | -29.8% | +103.6% | -11.4% | +17.6% | +2.9% | +18.8% | -16.5% | -52.6% | +2.2% | +105.5% | -36.2% | -90.6% | -72.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.